The Parkinsonian mimetic, 6-OHDA, impairs axonal transport in dopaminergic axons.
Lu X, Kim-Han JS, Harmon S, Sakiyama-Elbert SE, O'Malley KL.
Mol Neurodegener · research-article; journal article · DOI 10.1186/1750-1326-9-17 PUBLIKATIONSREGISTRET
Gå till forskningen.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för oxidopamine. Visa hela publikationsregistret
En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publikationer i urvalet
9 träffar3,4-dihydroxybenzalacetone protects against Parkinson's disease-related neurotoxin 6-OHDA through Akt/Nrf2/glutathione pathway.
Gunjima K, Tomiyama R, Takakura K, Yamada T, Hashida K, Nakamura Y, Konishi T, Matsugo S, Hori O.
J Cell Biochem · research support, non-u.s. gov't; journal article · DOI 10.1002/jcb.24643Naringenin protects against 6-OHDA-induced neurotoxicity via activation of the Nrf2/ARE signaling pathway.
Lou H, Jing X, Wei X, Shi H, Ren D, Zhang X.
Neuropharmacology · research support, non-u.s. gov't; journal article · DOI 10.1016/j.neuropharm.2013.11.02617β-estradiol delays 6-OHDA-induced apoptosis by acting on Nur77 translocation from the nucleus to the cytoplasm.
Renaud J, Chiasson K, Bournival J, Rouillard C, Martinoli MG.
Neurotox Res · research support, non-u.s. gov't; journal article · DOI 10.1007/s12640-013-9442-zRutin, a bioflavonoid antioxidant protects rat pheochromocytoma (PC-12) cells against 6-hydroxydopamine (6-OHDA)-induced neurotoxicity.
Magalingam KB, Radhakrishnan A, Haleagrahara N.
Int J Mol Med · journal article · DOI 10.3892/ijmm.2013.1375Effect of quercetin and desferrioxamine on 6-hydroxydopamine (6-OHDA) induced neurotoxicity in striatum of rats.
Haleagrahara N, Siew CJ, Ponnusamy K.
J Toxicol Sci · research support, non-u.s. gov't; journal article · DOI 10.2131/jts.38.25Neuroprotective potential of atorvastatin and simvastatin (HMG-CoA reductase inhibitors) against 6-hydroxydopamine (6-OHDA) induced Parkinson-like symptoms.
Kumar A, Sharma N, Gupta A, Kalonia H, Mishra J.
Brain Res · research support, non-u.s. gov't; journal article · DOI 10.1016/j.brainres.2012.06.050Endoplasmic reticulum stress and the unfolded protein response in cellular models of Parkinson's disease.
Ryu EJ, Harding HP, Angelastro JM, Vitolo OV, Ron D, Greene LA.
J Neurosci · research support, u.s. gov't, p.h.s.; research support, non-u.s. gov't; research-article; journal article · DOI 10.1523/jneurosci.22-24-10690.2002The determination of hydroxydopamines and other trace amines in the urine of parkinsonian patients and normal controls.
Andrew R, Watson DG, Best SA, Midgley JM, Wenlong H, Petty RK.
Neurochem Res · research support, non-u.s. gov't; journal article · DOI 10.1007/bf00978370